Recent DYN Stock Price | DYN Stock Predictions | |
$23.70 | +58.44% |
$37.55 |
Recent DYN Analyst Ratings Breakdown, Making DYN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 9 | 8 | 8 | 8 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the DYN stock predictions from the analysts covering Dyne Therapeutics Inc, we have collected all of the individual DYN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering DYN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since DYN stock predictions may vary widely, another useful metric to consider is the median DYN stock prediction, which represents the price at which half of the analysts
made DYN stock predictions that were higher and half made DYN stock predictions that were lower. This makes for a different take on the DYN stock predictions out there, as compared to average or mean.
And that median across all the individual DYN stock predictions was: $36.001 as of 2024-04-26.
The very highest of the DYN stock predictions for one year price target was $56.0, while the very lowest of the DYN stock predictions in the analyst group was
$25.0 (with a standard deviation of $9.488). Get the latest Zacks research report on DYN — FREE
Find out: DYN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ATH Stock Predictions
ORRF Stock Predictions
CLXT Stock Predictions
COMM Stock Predictions
TEN Stock Predictions
APLS Stock Predictions
WSM Stock Predictions
TFX Stock Predictions
SLRC Stock Predictions
|
|
Strong Buy (4.00 out of 4) 94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |